Youngjoo Kwon

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

ACS nano

Chemistry (Weinheim an der Bergstrasse, Germany)

Cancers

Chemical communications (Cambridge, England)

Ewha Womans University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ewha Womans University Mar 01 2005

South Korea

Professor :: College of Pharmacy

Publications

Jongyoon Shinn, Seojeong Park, Seonju Lee, Nayoon Park, Seojeong Kim, Seohui Hwang, James J Moon, Youngjoo Kwon, Yonghyun Lee
Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy. ACS nano 18 (6) (2024)
Jongyoon Shinn, Seojeong Park, Seonju Lee, Nayoon Park, Seojeong Kim, Seohui Hwang, James J Moon, Youngjoo Kwon, Yonghyun Lee
Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy. ACS nano 18 (6) (2024)
Jongyoon Shinn, Seojeong Park, Seonju Lee, Nayoon Park, Seojeong Kim, Seohui Hwang, James J Moon, Youngjoo Kwon, Yonghyun Lee
Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy. ACS nano (2024)
Arivazhagan Rajendran, Kirankumar Krishnamurthy, Seojeong Park, Eiji Nakata, Youngjoo Kwon, Takashi Morii
Topologically-Interlocked Minicircles as Probes of DNA Topology and DNA-Protein Interactions. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (22) (2022)
Chhabi Lal Chaudhary, Seungyun Ko, Chaerim Lee, Yerin Kim, Chanhyun Jung, Soonsil Hyun, Youngjoo Kwon, Jong-Soon Kang, Jae-Kyung Jung, Heesoon Lee
Design, Synthesis, and Cytotoxicity and Topoisomerase I/IIα Inhibition Activity of Pyrazolo[4,3- f ]quinoline Derivatives. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Seung Hee Seo, Soo-Yeon Hwang, Seohui Hwang, Sunjung Han, Hyojin Park, Yun-Sil Lee, Seung Bae Rho, Youngjoo Kwon
Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R. EMBO reports 23 (8) (2022)
Kyung-Hwa Jeon, Sang-Hyuck Park, Woong Jin Bae, Sae Woong Kim, Hyo Jung Park, Soomin Kim, Tae Hyung Kim, Seung Hwan Jeon, Ilbum Park, Hyun-Je Park, Youngjoo Kwon
Cannabidiol, a Regulator of Intracellular Calcium and Calpain. Cannabis and cannabinoid research (2022)
Arivazhagan Rajendran, Kirankumar Krishnamurthy, Seojeong Park, Eiji Nakata, Youngjoo Kwon, Takashi Morii
Topologically-Interlocked Minicircles as Probes of DNA Topology and DNA-Protein Interactions. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (22) (2022)
M D Hasanur Rahman, Partha Biswas, Dipta Dey, Md Abdul Hannan, Md Sahabuddin, Yusha Araf, Youngjoo Kwon, Talhah Bin Emran, Md Sarafat Ali, Md Jamal Uddin
An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGFβR-1. Life (Basel, Switzerland) 12 (11) (2022)
Soyeon Shim, Maddeboina Krishnaiah, Madhusudana Reddy Sankham, Inha Kim, Yoseob Lee, Irin Shin, A Reum Oh, Hwa Jeong Lee, Thi Ngoc Lan Vu, Jongmi Park, Sun Choi, Seojeong Park, Youngjoo Kwon, Sungsoon Fang, Dae-Kee Kim
Discovery of ( E )-3-(3-((2-Cyano-4'-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis. Journal of medicinal chemistry 65 (14) (2022)
Byeong Seong Ki, Sung Han Shim, Chanhyeok Park, Hyunjin Yoo, Hyeonwoo La, Ok-Hee Lee, Youngjoo Kwon, David G Skalnik, Yuki Okada, Ho-Geun Yoon, Jin-Hoi Kim, Kwonho Hong, Youngsok Choi
Epigenetic regulator Cfp1 safeguards male meiotic progression by regulating meiotic gene expression. Experimental & molecular medicine 54 (8) (2022)
Young-Ah You, Soo-Yeon Hwang, Soo-Min Kim, Seojeong Park, Ga-In Lee, Sunwha Park, AbuZar Ansari, Jeongae Lee, Youngjoo Kwon, Young Ju Kim
Identification of Indicators for Preterm Birth Using Retinoid Metabolites. Metabolites 11 (7) (2021)
Joowon Yim, Hee Hyun Lim, Youngjoo Kwon
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development. Archives of pharmacal research 44 (5) (2021)
Hawon Yoo, Seul-Ki Choi, Jaeok Lee, So Hyeon Park, You Na Park, Soo-Yeon Hwang, Jae-Ho Shin, Younghwa Na, Youngjoo Kwon, Hwa Jeong Lee, Yun-Sil Lee
Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers. Pharmaceutics 13 (5) (2021)
Seung-Hee Seo, Shamrat Kumar Paul, Mita Shikder, Mushira Khanam, Popy Ghosh, Tasnin Al Hasib, Kazi Ahsan Ahmed, Suranjana Sikdar, Md Jamal Uddin, Youngjoo Kwon
An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma. Cancers 13 (13) (2021)
Soo-Yeon Hwang, Soo-Yeon Park, Jung Yeon Hong, Soo Yeon Lee, Jae-Ho Shin, Younghwa Na, Myung Hyun Sohn, Ho-Geun Yoon, Youngjoo Kwon
Field-based rational design of p300 histone acetyltransferase inhibitor and systematic evaluation as an anti-fibrotic agent. Chemical communications (Cambridge, England) 56 (68) (2021)
Kyung-Hwa Jeon, Seojeong Park, Hae Jin Jang, Soo-Yeon Hwang, Aarajana Shrestha, Eung-Seok Lee, Youngjoo Kwon
AK-I-190, a New Catalytic Inhibitor of Topoisomerase II with Anti-Proliferative and Pro-Apoptotic Activity on Androgen-Negative Prostate Cancer Cells. International journal of molecular sciences 22 (20) (2021)
Soo-Yeon Hwang, Seul-Ki Choi, Seung Hee Seo, Hyunji Jo, Jae-Ho Shin, Younghwa Na, Yun-Sil Lee, Youngjoo Kwon
Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance. Cancers 12 (6) (2020)
Seojeong Park, Soo-Yeon Hwang, Jaeho Shin, Hyunji Jo, Younghwa Na, Youngjoo Kwon
A chromenone analog as an ATP-competitive, DNA non-intercalative topoisomerase II catalytic inhibitor with preferences toward the alpha isoform. Chemical communications (Cambridge, England) 55 (85) (2019)

Youngjoo Kwon.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Youngjoo Kwon